BTA
Click for more information
0.00% 57.0¢ biota holdings limited

research data sankyo tjw, page-3

  1. TJW
    716 Posts.
    clock Created with Sketch.
    27/03/07
    21:35
    Post #: 2306660
    DMA

    Sankyo/Biota probably thought the time is ripe because of Tamiflu problem in Japan and the zero sale of Relenza for the seasonal flu market by GSK.

    Hope the claim is 500 million US dollars rather than AUSSIE dollars.

    Cheers
    BTA Price at posting: 0.0¢ Sentiment: Buy Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.